Select Medical
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
1,233% more call options, than puts
Call options by funds: $200K | Put options by funds: $15K
75% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 68
5.53% more ownership
Funds ownership: 75.62% [Q3] → 81.15% (+5.53%) [Q4]
5% less funds holding
Funds holding: 283 [Q3] → 268 (-15) [Q4]
20% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 60
42% less capital invested
Capital invested by funds: $3.43B [Q3] → $1.99B (-$1.44B) [Q4]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$21
27%
upside
Avg. target
$22
33%
upside
High target
$23
39%
upside
2 analyst ratings
1 positive
50%
1 neutral
50%
0 negative
0%
RBC Capital Ben Hendrix 41% 1-year accuracy 27 / 66 met price target | 39%upside $23 | Outperform Maintained | 24 Feb 2025 |
UBS A.J. Rice 41% 1-year accuracy 7 / 17 met price target | 27%upside $21 | Neutral Maintained | 3 Jan 2025 |
Financial journalist opinion
Negative
Zacks Investment Research
1 month ago
Select Medical Q4 Earnings Miss Estimates, Stock Down 7.2%
SEM expects revenues to be between $5.4 billion and $5.6 billion, the mid-point of which implies 5.8% growth from the 2024 figure of $5.2 billion.
Neutral
Seeking Alpha
1 month ago
Select Medical Holdings Corporation (SEM) Q4 2024 Earnings Call Transcript
Select Medical Holdings Corporation (NYSE:SEM ) Q4 2024 Earnings Conference Call February 21, 2025 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - Senior Executive Vice President of Strategic Finance and Operations Michael Malatesta - Executive Vice President and CFO Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendricks - RBC Capital Markets Joanna Gajuk - Bank of America Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Fourth Quarter and Full Year 2024 Results and the Company's Business Outlook. Speaking today are the Company's Executive Chairman and Co-Founder, Robert Ortenzio; the Company's Senior Executive Vice President of Strategic Finance and Operations, Martin Jackson; and Executive Vice President and CFO, Michael Malatesta.
Negative
Zacks Investment Research
1 month ago
Select Medical (SEM) Lags Q4 Earnings Estimates
Select Medical (SEM) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.36 per share a year ago.
Neutral
PRNewsWire
1 month ago
Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2024, Its 2025 Business Outlook, and Cash Dividend
MECHANICSBURG, Pa. , Feb. 20, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2024, its 2025 business outlook, and the declaration of a cash dividend.
Neutral
PRNewsWire
2 months ago
Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2024 Results on Thursday, February 20, 2025
MECHANICSBURG, Pa. , Jan. 23, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and year ended December 31, 2024 on Thursday, February 20, 2025 after the market closes.
Neutral
Zacks Investment Research
2 months ago
SEM Plunges 48.2% in 6 Months: Should You Buy, Hold or Sell the Stock?
Rising expenses and high leverage are impacting Select Medical's prospects.
Neutral
PRNewsWire
3 months ago
Select Medical Holdings Corporation Closes Offering of $550 Million of 6.250% Senior Notes due 2032 by Select Medical Corporation
MECHANICSBURG, Pa. , Dec. 3, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation, a wholly-owned subsidiary of Holdings ("Select"), has completed a private offering (the "Offering") of $550.0 million in aggregate principal amount of its 6.250% senior notes due 2032 (the "notes").
Positive
Zacks Investment Research
3 months ago
5 Low Price-to-Book Value Stocks to Buy in December
The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, SEM, AXS, ZIM and PFE are some such stocks.
Positive
Zacks Investment Research
4 months ago
All You Need to Know About Select Medical (SEM) Rating Upgrade to Buy
Select Medical (SEM) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Negative
Zacks Investment Research
4 months ago
After Plunging -38.05% in 4 Weeks, Here's Why the Trend Might Reverse for Select Medical (SEM)
The heavy selling pressure might have exhausted for Select Medical (SEM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Charts implemented using Lightweight Charts™